• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Solara Share Price

    Solara Active Pharma Sciences Share PriceSolara Active Pharma Sciences

    Small Cap 4.9k Result
    ₹332.4
    -2 (-0.6%)
    As on 10 December, 2023 | 12:59 BSE: 541540 NSE: SOLARAISIN: INE624Z01016

    Solara Active Pharma Sciences Performance

    Day Range

    • Low 331.50
    • High 338.15
    ₹ 332.4

    52 Week Range

    • Low 286.00
    • High 495.00
    ₹ 332.4
    • Open Price335.45
    • Previous Close334.40
    • Volume37629

    Start SIP in Solara Active Pharma Sciences

    Start SIP

    Solara Active Pharma Sciences Share Price

    • Over 1 Month -1.22%
    • Over 3 Month -10.05%
    • Over 6 Month -6.25%
    • Over 1 Year -24.85%

    Solara Active Pharma Sciences Key Statistics

    P/E Ratio -36.8
    PEG Ratio -0.5
    Market Cap Cr 1,197
    Price to Book Ratio 0.8
    EPS -6
    Dividend 0
    Relative Strength Index 47.22
    Money Flow Index 46.09
    MACD Signal 0.06
    Average True Range 9.06

    Solara Active Pharma Sciences Investment Rating

    • Master Rating:

    • Solara Active Pharma Scis has an operating revenue of Rs. 1,552.92 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of -3% needs improvement, ROE of -1% is poor and needs improvement. The company has a reasonable debt to equity of 16%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 12 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Solara Active Pharma Sciences Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 425352381395338330361
    Operating Expenses Qtr Cr 388333329349311320348
    Operating Profit Qtr Cr 38195245281013
    Depreciation Qtr Cr 26262628292828
    Interest Qtr Cr 24262224222321
    Tax Qtr Cr 0-1020-9-15-33
    Net Profit Qtr Cr -15-2060-10-190
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,4661,287
    Operating Expenses Annual Cr 1,3101,188
    Operating Profit Annual in Cr 13480
    Depreciation Cr 111112
    Interest Annual Cr 9075
    Tax Annual Cr -23-33
    Net Profit Annual Cr -22-59
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 156-242
    Cash from Investing Activity Annual Cr -81-243
    Cash from Financing Annual Activity Cr -113334
    Net Cash Flow Annual Cr -38-151
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,5031,527
    Fixed Assets Annual Cr 1,5801,573
    Total Non Current Assets Annual Cr 1,7041,710
    Total Current Assets Annual Cr 1,1911,240
    Total Assets Annual Cr 2,8952,950
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 418424
    ROE Annual % -1-4
    ROCE Annual % 3-1
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 118
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 425352381395338330361
    Operating Expenses Qtr Cr 388333332350311318347
    Operating Profit Qtr Cr 38194945281314
    Depreciation Qtr Cr 26262628292828
    Interest Qtr Cr 24252224222321
    Tax Qtr Cr 0-1010-9-15-33
    Net Profit Qtr Cr -17-2040-10-162
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1,4661,288
    Operating Expenses Annual Cr 1,3101,188
    Operating Profit Annual in Cr 13480
    Depreciation Cr 111112
    Interest Annual Cr 9075
    Tax Annual Cr -23-33
    Net Profit Annual Cr -22-58
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 156-242
    Cash from Investing Activity Annual Cr -81-243
    Cash from Financing Annual Activity Cr -113334
    Net Cash Flow Annual Cr -38-151
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 1,5001,525
    Fixed Assets Annual Cr 1,2371,230
    Total Non Current Assets Annual Cr 1,7121,713
    Total Current Assets Annual Cr 1,1881,239
    Total Assets Annual Cr 2,8992,953
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 417424
    ROE Annual % -1-4
    ROCE Annual % 3-1
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 118
    Invest in Solara Active Pharma Sciences

    Solara Active Pharma Sciences Technicals

    EMA & SMA

    Current Price
    ₹332.4
    -2 (-0.6%)
    pointer
    • Bullish Moving Average
    • ___
    • 1
    • Bearish Moving Average
    • ___
    • 15
    • 20 Day
    • ₹334.71
    • 50 Day
    • ₹338.76
    • 100 Day
    • ₹348.77
    • 200 Day
    • ₹374.66
    • 20 Day
    • ₹336.05
    • 50 Day
    • ₹334.88
    • 100 Day
    • ₹354.80
    • 200 Day
    • ₹361.10

    Solara Active Pharma Sciences Resistance and Support

    PIVOT
    ₹334.02
    Resistance
    First Resistance 336.53
    Second Resistance 340.67
    Third Resistance 343.18
    RSI 47.22
    MFI 46.09
    MACD Single Line 0.06
    MACD -0.16
    Support
    First Resistance 329.88
    Second Resistance 327.37
    Third Resistance 323.23

    Solara Active Pharma Sciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 49,323 2,521,392 51.12
    Week 156,137 12,085,004 77.4
    1 Month 101,161 5,708,539 56.43
    6 Month 172,210 7,358,540 42.73

    Solara Active Pharma Sciences Result Highlights

    Solara Active Pharma Sciences Synopsis

    NSE-Medical-Diversified

    Solara Active Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 1443.81 Cr. and Equity Capital is Rs. 36.00 Cr. for the Year ended 31/03/2023. Solara Active Pharma Sciences Ltd. is a Public Limited Listed company incorporated on 23/02/2017 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH2017PLC291636 and registration number is 291636.
    Market Cap 1,197
    Sales 1,553
    Shares in Float 2.27
    No of funds 42
    Yield
    Book Value 0.8
    U/D Vol ratio 1.6
    LTDebt / Equity 16
    Alpha -0.11
    Beta 0.48

    Solara Active Pharma Sciences

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 37.19%39.31%40.97%40.4%
    Mutual Funds 1.75%1.71%2.21%2.51%
    Foreign Portfolio Investors 17.86%18.71%19.3%19.26%
    Financial Institutions/ Banks 0.04%
    Individual Investors 19.84%18.06%16.23%16.54%
    Others 23.32%22.21%21.29%21.29%

    Solara Active Pharma Sciences Management

    Name Designation
    Mr. Poorvank Purohit Managing Director & CEO
    Mr. Kartheek Chintalapati Raju Non Executive Director
    Mr. Ankur Nand Thadani Non Executive Director
    Mr. Arun Kumar Non Executive Director
    Mr. R Ramakrishnan Independent Director
    Dr. Kausalya Santhanam Independent Director

    Solara Active Pharma Sciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Solara Active Pharma Sciences Corporate Action

    Date Purpose Remarks
    2023-11-14 Quarterly Results
    2023-08-14 Quarterly Results (Revised) per share(50%)Final Dividend
    2023-07-05 Right issue of Equity Shares
    2023-05-12 Audited Results
    2023-01-25 Quarterly Results

    Solara Active Pharma Sciences MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Flexi Cap Fund Growth 17,029
    Aditya Birla Sun Life Mid Cap Fund Growth 4,252
    Aditya Birla Sun Life Manufacturing Equity Fund Regular Plan Growth 704
    Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 461
    Motilal Oswal S&P BSE Healthcare ETF 8

    Solara Active Pharma Sciences FAQs

    What is Share Price of Solara Active Pharma Sciences ?

    Solara Active Pharma Sciences share price is ₹332 As on 10 December, 2023 | 12:45

    What is the Market Cap of Solara Active Pharma Sciences ?

    The Market Cap of Solara Active Pharma Sciences is ₹1196.5 Cr As on 10 December, 2023 | 12:45

    What is the P/E ratio of Solara Active Pharma Sciences ?

    The P/E ratio of Solara Active Pharma Sciences is -36.8 As on 10 December, 2023 | 12:45

    What is the PB ratio of Solara Active Pharma Sciences ?

    The PB ratio of Solara Active Pharma Sciences is 0.8 As on 10 December, 2023 | 12:45

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.